Middle East & Africa Circulating Tumor Cells Market Size & Outlook

The circulating tumor cells market in Middle East & Africa is expected to reach a projected revenue of US$ 270.6 million by 2030. A compound annual growth rate of 8.2% is expected of Middle East & Africa circulating tumor cells market from 2024 to 2030.
Revenue, 2023 (US$M)
$155.4
Forecast, 2030 (US$M)
$270.6
CAGR, 2024 - 2030
8.2%
Report Coverage
Middle East & Africa

Middle East & Africa circulating tumor cells market, 2018-2030 (US$M)

Middle

MEA circulating tumor cells market highlights

  • The MEA circulating tumor cells market generated a revenue of USD 155.4 million in 2023.
  • The market is expected to grow at a CAGR of 8.2% from 2024 to 2030.
  • In terms of segment, ctc detection & enrichment methods was the largest revenue generating technology in 2023.
  • CTC Analysis is the most lucrative technology segment registering the fastest growth during the forecast period.
  • Country-wise, UAE is expected to register the highest CAGR from 2024 to 2030.


MEA data book summary

Market revenue in 2023USD 155.4 million
Market revenue in 2030USD 270.6 million
Growth rate8.2% (CAGR from 2023 to 2030)
Largest segmentCtc detection & enrichment methods
Fastest growing segmentCTC Analysis
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationCTC Detection & Enrichment Methods, CTC Direct Detection Methods, CTC Analysis
Key market players worldwideQiagen NV, Bio-Techne Corp, Praxis Precision Medicines Inc Ordinary Shares, Aviva PLC, Biocept Inc, Neurocrine Biosciences Inc, Greiner Bio-One, Miltenyi Biotec, Icon PLC, Ecolab Inc, Arcus Biosciences Inc, Epic Corp, Screen Holdings Co Ltd, Menarini Group, Vtex Ordinary Shares - Class A, Sysmex Corp, STEMCELL Technologies


Other key industry trends

  • In terms of revenue, MEA region accounted for 1.4% of the global circulating tumor cells market in 2023.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 6,739.0 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Circulating Tumor Cells Market Companies

Name Profile # Employees HQ Website

Middle East & Africa circulating tumor cells market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to circulating tumor cells market will help companies and investors design strategic landscapes.


Ctc detection & enrichment methods was the largest segment with a revenue share of 64.86% in 2023. Horizon Databook has segmented the Middle East & Africa circulating tumor cells market based on ctc detection & enrichment methods, ctc direct detection methods, ctc analysis covering the revenue growth of each sub-segment from 2018 to 2030.


Considerable increase in the prevalence of chronic and infectious diseases in the African region due to low living standards, unhealthy diet, and industrial & agricultural pollution, has led to an increase in the need for cheaper generic treatment. Moreover, the ongoing development of healthcare infrastructure is providing ample opportunities to support market growth.

The pricing policies in Saudi Arabia and regulatory framework reforms may further contribute to market growth by creating growth opportunities for local players. A greater proportion of people in African countries belong to the low-income group. Hence, the rise in demand for affordable substitutes coupled with availability of generic products is anticipated to drive the market.

In addition, government initiatives to increase the adoption of generic drugs for reducing healthcare costs are expected to drive growth of the branded generics market in the MEA.

Reasons to subscribe to Middle East & Africa circulating tumor cells market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Middle East & Africa circulating tumor cells market databook

  • Our clientele includes a mix of circulating tumor cells market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa circulating tumor cells market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa circulating tumor cells market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

MEA circulating tumor cells market size, by country, 2018-2030 (US$M)

Middle East & Africa Circulating Tumor Cells Market Outlook Share, 2023 & 2030 (US$M)

MEA circulating tumor cells market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more